Comrade Steve

an hour before your post some a guy started screaming about Insurance companies and the lack of coverage for eSight. I simply pointed out his seeming derangement and the fact that eSight has just finished it's clinical trials at Johns Hopkins among others.  As it's deemed a Class I medical device after clinical there are still lots hoops to jump through.  Review, results, determinations. therapeutic modalities etc then the Insurance Companies will start all over with it again. In what universe is a $10,000 device approved by "We want the business,  approve it and  buy it from us."